Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441
This multidistrict litigation consolidates for pretrial purposes all federal cases alleging that dual modular hip replacement prostheses sold under the names "Rejuvenate®" and "ABG II" were defective and have caused injury to the plaintiffs. The defendants in this litigation include, but are not limited to, Howmedica Osteonics Corp d/b/a Stryker Orthopaedics, Stryker Corporation, and Stryker Sales Corporation.
In the federal court system, when multiple cases are pending in several different district courts that involve common questions of fact, the law provides that the Judicial Panel on Multi District Litigation ("JPML") can transfer all of the federal cases to one federal judge, if centralization will serve the convenience of the parties and the witnesses and promote the just and efficient conduct of the litigation for pretrial purposes.
On June 12, 2013, the JPML determined that these actions involve common questions of fact "concerning design, manufacture, marketing and performance of Stryker's recalled Stryker Rejuvenate and ABG II modular-neck stems." The JPML also found that "centralization will eliminate duplicative discovery, prevent inconsistent pretrial rulings on discovery and other issues, and conserve the resources of the parties, their counsel and the judiciary."
To coordinate among all of the lawyers representing parties in these actions throughout the United States, the United States District Court for the District of Minnesota has appointed Lead Counsel and Liaison Counsel. Please view the Contacts page for more information.